The executive leadership team of Cyclo Therapeutics is headed by N. Scott Fine, who serves as the Chief Executive Officer. Bringing extensive experience in investment banking, corporate restructuring, and healthcare financial advisory work, he directs the strategic management, operational execution, and clinical development initiatives of the enterprise as it advances its specialized therapeutic pipeline for rare and neurological diseases through critical clinical trials and regulatory milestones.